TFIPS
GILD icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Gilead Sciences GILD Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
5,568
+459
+9% +$60.5K 0.2% 82
2026
Q1 		$712K Sell
5,109
-939
-16% -$131K 0.24% 65
2025
Q4 		$742K Sell
6,048
-617
-9% -$75K 0.19% 69
2025
Q3 		$740K Sell
6,665
-2,907
-30% -$330K 0.18% 68
2025
Q2 		$1.06M Sell
9,572
-1,230
-11% -$131K 0.3% 43
2025
Q1 		$1.21M Buy
10,802
+1,130
+12% +$117K 0.41% 37
2024
Q4 		$893K Sell
9,672
-270
-3% -$24.3K 0.29% 44
2024
Q3 		$834K Buy
9,942
+670
+7% +$51.1K 0.3% 40
2024
Q2 		$636K Hold
9,272
– – 0.24% 50
2024
Q1 		$679K Buy
9,272
+300
+3% +$23.1K 0.29% 43
2023
Q4 		$727K Buy
+8,972
New +$698K 0.33% 36
2021
Q3 		$491K Buy
7,027
+760
+12% +$53.4K 0.59% 29
2021
Q2 		$432K Hold
6,267
– – 0.51% 32
2021
Q1 		$405K Hold
6,267
– – 0.59% 29
2020
Q4 		$365K Buy
+6,267
New +$378K 0.38% 37

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's GILD Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Gilead Sciences (GILD) stake by 9% in Q2 2026, buying an estimated $60.5K and bringing the position to 5,568 shares worth $703K. The position accounts for 0.2% of the portfolio, ranked #82.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in GILD in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.21M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 5,568 shares of Gilead Sciences worth $703K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 459 Gilead Sciences shares in Q2 2026, an estimated $60.5K.
  • Gilead Sciences made up 0.2% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #82 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Gilead Sciences in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Gilead Sciences position peaked at $1.21M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.